Latest Slides

Filter Science News

LBCT Shortcuts

Sunday, Nov. 4, 2012 Monday, Nov 5, 2012 Tuesday, Nov. 6, 2012

LBCT.01: Practice Implications for CAD and VTE

LBCT.03: Treatments for Prevention of Cardiovascular Events: A Population Perspective

LBCT.05: Cell-Based Therapies for Myocardial Regeneration

LBCT.02: Health Economics and Quality of Life in Contemporary Trials

LBCT.04: Novel Treatments for Managing Lipid Disorders

LBCT.06: Management of LV Dysfunction: Devices and Drugs


Science News from AHA12

CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Douglas L. Mann Washington University School of Medicine, Barnes Jewish Hospital St. Louis, MO   A Multicenter, Randomized Study Assessing the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Advanced Heart... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 3:33 PM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Joerg Schwab University of Bonn Bonn, Germany   Dedicated ICD Programming Reduces the Number of Inappropriate Therapies in a Real World Primary Prevention ICD Population: The DECREASE - Trial   Presentation Slides | Abstract |... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 3:25 PM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Jeffrey H. Lawson Duke University Durham, NC   First-in-Man Clinical Evaluation of a Novel Tissue Engineered Vascular Graft   Presentation Slides  | Abstract | Presentation Audio | Discussant Audio | Discussant Slides ... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 3:10 PM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Amy Sarma Brigham and Women's Hospital  Boston, MA   The Incidence of Kidney Injury for Patients Treated with Intensive versus Less Potent Statin Therapy after an Acute Coronary Syndrome   Presentation Slides |... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 3:02 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Michael J. Koren Jacksonville Center for Clinical Research Jacksonville, FL   Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145 versus Standard of Care in 1104 Patients: 52-week Results... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 1:23 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Arshed Ali Quyyumi Emory University Atlanta, GA   Effect of Angiotensin II Type I Receptor Blockade on Carotid Artery Atherosclerosis: A Randomized Trial Comparing Valsartan and Placebo (EFFERVESCENT)    Presentation... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 1:10 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Thomas J Wang Vanderbilt University Nashville, TN   Daylight: Vitamin D Therapy in Individuals at High Risk of Hypertension    Presentation Slides | Abstract | Presentation Audio | Discussant Audio | Discussant Slides ... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 12:50 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Tobias Bonten Leiden University Medical Center Leiden, Netherlands   Does Aspirin Intake at Bedtime Decrease Blood Pressure and Morning Peak of Platelet Reactivity?: A Randomized Cross-over Trial    Presentation Slides |... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 12:11 PM CST
CS.02: Biomarkers in Populations   Lijing L. Yan The George Institute for Global Health at Peking University Health Science Center Beijing, China   China Rural Health Initiative - Primary Care Provider Study: A Large Cluster-Randomized Controlled Trial of High Cardiovascular Risk Management in Rural China ... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 11:53 AM CST
CS.02: Biomarkers in Populations   Jack V. Tu Institute for Clinical Evaluative Sciences Toronto, ON, Canada   Ten-Year Incidence Rates of Major Cardiovascular Events in 697,690 Immigrants to Ontario, Canada, by Ethnic Group and Country of Birth   Presentation Slides  | Abstract | Presentation... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 11:34 AM CST
CS.02: Biomarkers in Populations   Stella Aslibekyan University of Alabama at Birmingham Birmingham, AL   CPT1A Methylation is a Novel Epigenetic Marker of Cardiovascular Risk    Presentation Slides  | Abstract | Presentation Audio | Discussant Slides | Discussant Audio   ... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 11:15 AM CST
CS.02: Biomarkers in Populations   Eric Van Belle Hôpital Cardiologique Lille, France   Outcome Impact of Coronary Revascularization Strategy - Reclassification With Fractional Flow Reserve (FFR) at time of diagnostic angiography: Insights from a Large French Multicenter FFR Registry (R3F)  ... more...
Posted by Summer PONeditor on AHA Scientific Sessions Nov 20, 2013 10:59 AM CST
New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis ENGAGE AF-TIMI 48 Primary Results Presentation Slides | Summary Slide | Abstract | Presentation Audio | Discussant Audio  | Discussant Slides Robert P. Giugliano Brigham and Women's Hospital Boston, MA AHA13 on the PON more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 20, 2013 10:47 AM CST
New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis The Clarification of Optimal Anticoagulation through Genetics (COAG) Trial Presentation Slides | Summary Slide | Abstract | Presentation Audio | Discussant Audio | Discussant Slides Stephen E. Kimmel University of Pennsylvania School of Medicine Philadelphia, PA... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 20, 2013 10:25 AM CST
New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study  Presentation Slides | Summary Slide | Abstract | Presentation Audio | Discussant Audio | Discussant... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 20, 2013 10:16 AM CST
New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis RADAR-AF Trial. A Randomized Multicenter Comparison of Radiofrequency Catheter Ablation of Drivers versus Circumferential Pulmonary Vein Isolation in Patients with Atrial Fibrillation Presentation Slides | Summary Slide | Abstract | Presentation Audio | Discussant... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 20, 2013 10:05 AM CST
Therapeutic Advances in Coronary and Peripheral Vascular Disease A Randomized Multicenter Clinical Trial of Renal Artery Stenting in Preventing Cardiovascular and Renal Events: Results of the CORAL Study  Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio Christopher J. Cooper ... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 19, 2013 9:44 AM CST
Therapeutic Advances in Coronary and Peripheral Vascular Disease Randomized Comparison of Endovascular Revascularization Plus Supervised Exercise Therapy Versus Supervised Exercise Therapy Only in Patients With Peripheral Artery Disease and Intermittent Claudication: Results of the Endovascular Revascularization and Supervised... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 19, 2013 9:36 AM CST
Therapeutic Advances in Coronary and Peripheral Vascular Disease Secretory Phospholipase A2 Inhibition with Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome: Results of the VISTA-16 Study Presentation Slides | Discussant Slides | Summary Slide | Abstract | Presentation Audio | Discussant Audio ... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 19, 2013 9:28 AM CST
Therapeutic Advances in Coronary and Peripheral Vascular Disease One Year Mortality in STEMI Patients Randomized to Primary PCI or a Pharmaco-invasive Strategy. The Stream 1 Year Follow-up   Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio Peter Sinnaeve Univ of Leuven Leuven, Belgium ... more...
Posted by Alyson PON Editor on AHA Scientific Sessions Nov 19, 2013 9:20 AM CST